gemcitabine

NEW YORK — September 28, 2026 Immuneering Corporation presented new data at the 2026 AACR Conference on Pancreatic Cancer...

REDWOOD CITY, Calif. — September 14, 2026 Revolution Medicines, Inc. announced that the U.S. Food and Drug Administration (FDA)...

Melbourne, Australia – August 27, 2026 Propanc Biopharma announced new preclinical and early translational data for PRP in pancreatic...

Irving, Texas, United States, Aug 27, 2026 Caris Life Sciences has announced the publication of a study in npj...

Mountain View, Calif. – August 25, 2026 RenovoRx highlighted the publication of pharmacokinetic and pharmacodynamic (PK/PD) data supporting its...

Ramat Gan, Israel — August 17, 2026 Can-Fite BioPharma Ltd. announced new preclinical findings showing that namodenoson enhanced the...

ROCKVILLE, Md., August 6, 2026 Theriva Biologics announced that the first patient has been dosed in the VIRAGE2 Phase...

BOSTON, June 17, 2026 Verastem Oncology announced positive updated safety and efficacy findings from the Phase 1b/2a RAMP 205...

WILMINGTON, Del. & SAN FRANCISCO, May 19, 2026 Incyte and Edison Scientific have announced a strategic collaboration aimed at...

SAN ANTONIO, Texas, May 19, 2026 Valion Bio, Inc. has announced a high-level joint engagement with senior officials from...